List view / Grid view

Cameron Owen (CEO of rBIO)

 

article

Next-gen biotech: rBIO’s approach to affordable insulin solutions

rBIO is transforming the biosimilar insulin market with a novel…

4 April 2025 | By

rBIO is transforming the biosimilar insulin market with a novel biomanufacturing platform designed to reduce production costs while maintaining high-quality standards. CEO Cameron Owen shares how their approach is shaping drug discovery and improving patient access to life-saving treatments.